These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32159116)

  • 21. Prevention of stroke in patients with atrial fibrillation.
    Olsson SB; Halperin JL
    Semin Vasc Med; 2005 Aug; 5(3):285-92. PubMed ID: 16123916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48.
    Bonaca MP; Antman EM; Cunningham JW; Wiviott SD; Murphy SA; Halperin JL; Weitz JI; Grosso MA; Lanz HJ; Braunwald E; Giugliano RP; Ruff CT
    Eur Heart J Cardiovasc Pharmacother; 2022 Sep; 8(7):695-706. PubMed ID: 34962979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of cardioversions as an additional risk factor for stroke in atrial fibrillation - the FinCV-4 study.
    Jaakkola S; Kiviniemi TO; Jaakkola J; Pouru JP; Nuotio I; Vasankari T; Hartikainen JEK; Airaksinen KEJ
    Ann Med; 2022 Dec; 54(1):1452-1458. PubMed ID: 35594342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal stroke preventive strategy for patients aged 80 years or older with atrial fibrillation: a systematic review with traditional and network meta-analysis.
    Lee KH; Chen YF; Yeh WY; Yeh JT; Yang TH; Chou CY; Chang YL; Wang WT; Chiang CE; Chen CH; Cheng HM
    Age Ageing; 2022 Dec; 51(12):. PubMed ID: 36571776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial Fibrillation, Type 2 Diabetes, and Non-Vitamin K Antagonist Oral Anticoagulants: A Review.
    Plitt A; McGuire DK; Giugliano RP
    JAMA Cardiol; 2017 Apr; 2(4):442-448. PubMed ID: 28122078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on atrial fibrillation: focus on stroke risk reduction strategies.
    Potpara T; Jokic V; Medic B; Prostran M; Lip G
    Minerva Med; 2015 Oct; 106(5):259-273. PubMed ID: 26495822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous Left Atrial Appendage Occlusion: An Emerging Option in Patients with Atrial Fibrillation at High Risk of Bleeding.
    Cimmino G; Loffredo FS; Gallinoro E; Prozzo D; Fabiani D; Cante L; Salerno G; Cappelli Bigazzi M; Golino P
    Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34063719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: systematic review and meta-analysis of 22 studies and 440 281 patients.
    Silverio A; Di Maio M; Prota C; De Angelis E; Radano I; Citro R; Carrizzo A; Ciccarelli M; Vecchione C; Capodanno D; Galasso G
    Eur Heart J Cardiovasc Pharmacother; 2021 Apr; 7(FI1):f20-f29. PubMed ID: 31830264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of atrial fibrillation: two decades of progress - a scientific statement from the European Cardiac Arrhythmia Society.
    Lévy S; Steinbeck G; Santini L; Nabauer M; Maceda DP; Kantharia BK; Saksena S; Cappato R
    J Interv Card Electrophysiol; 2022 Oct; 65(1):287-326. PubMed ID: 35419669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease.
    Potpara TS; Jokic V; Dagres N; Larsen TB; Lane DA; Hindricks G; Lip GY
    Curr Med Chem; 2016; 23(19):2055-69. PubMed ID: 26861000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Gender With Clinical Outcomes in a Contemporary Cohort of Patients With Atrial Fibrillation Receiving Oral Anticoagulants.
    Kim M; Kim J; Kim JB; Park J; Park JK; Kang KW; Shim J; Choi EK; Lee YS; Park HW; Joung B
    Korean Circ J; 2022 Aug; 52(8):593-603. PubMed ID: 35656931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
    J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection of Non-vitamin K Antagonist Oral Anticoagulant for Stroke Prevention in Atrial Fibrillation Based on Patient Profile: Perspectives from Vietnamese Experts. Part 1.
    Quang Ho TH; Ton MT; Nguyen VL; Pham HM; Hoang SV; Vo NT; Nguyen TQ; Pham LT; Mai TD; Nguyen TH
    Eur Cardiol; 2023; 18():e61. PubMed ID: 38174217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy.
    Pastori D; Mezzaroma I; Pignatelli P; Violi F; Lip GYH
    Br J Clin Pharmacol; 2019 Mar; 85(3):508-515. PubMed ID: 30575989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving risk prediction for death, stroke and bleeding in Asian patients with atrial fibrillation.
    Krittayaphong R; Kanjanarutjawiwat W; Wisaratapong T; Lip GYH
    Eur J Clin Invest; 2023 Feb; 53(2):e13886. PubMed ID: 36197442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stroke in Atrial Fibrillation and Other Atrial Dysrhythmias.
    Ozdemir H; Sagris D; Lip GYH; Abdul-Rahim AH
    Curr Cardiol Rep; 2023 May; 25(5):357-369. PubMed ID: 36976496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel oral anticoagulants in non-valvular atrial fibrillation.
    Potpara TS; Lip GY
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):115-29. PubMed ID: 23953900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction.
    Mahmood M; Lip GYH
    Rev Esp Cardiol (Engl Ed); 2018 Oct; 71(10):847-855. PubMed ID: 29958809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.